STOCK TITAN

Allegion (NYSE: ALLE) SVP granted new stock options and RSUs

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Allegion plc reported that SVP and General Counsel Joseph Blasko received new equity awards. He was granted a stock option for 5,248 shares at an exercise price of $0.00 per share and an award linked to 1,384 ordinary shares, both classified as acquisitions.

The footnotes state that the restricted stock units vest in equal annual installments on February 19, 2027, February 19, 2028, and February 19, 2029, and the stock option vests on the same schedule. No open-market purchases or sales were reported in this filing.

Positive

  • None.

Negative

  • None.
Insider Blasko Joseph
Role SVP and General Counsel
Type Security Shares Price Value
Grant/Award Stock Option (Right to Buy) 5,248 $0.00 --
Grant/Award Ordinary Shares 1,384 $0.00 --
Holdings After Transaction: Stock Option (Right to Buy) — 5,248 shares (Direct); Ordinary Shares — 2,909 shares (Direct)
Footnotes (1)
  1. Restricted stock units that vest in equal annual installments on February 19, 2027, February 19, 2028 and February 19, 2029. A stock option that vests in equal annual installments on February 19, 2027, February 19, 2028 and February 19, 2029.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Blasko Joseph

(Last) (First) (Middle)
C/O SCHLAGE LOCK COMPANY LLC
11819 N. PENNSYLVANIA STREET

(Street)
CARMEL IN 46032

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Allegion plc [ ALLE ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
SVP and General Counsel
3. Date of Earliest Transaction (Month/Day/Year)
02/19/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Ordinary Shares 02/19/2026 A 1,384(1) A $0 2,909 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy) $162.665 02/19/2026 A 5,248 (2) 02/19/0036 Ordinary Shares 5,248 $0 5,248 D
Explanation of Responses:
1. Restricted stock units that vest in equal annual installments on February 19, 2027, February 19, 2028 and February 19, 2029.
2. A stock option that vests in equal annual installments on February 19, 2027, February 19, 2028 and February 19, 2029.
Remarks:
/s/ Tandra M. Foster, Attorney-In-Fact 02/23/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Allegion (ALLE) report for Joseph Blasko?

Allegion reported equity awards to SVP and General Counsel Joseph Blasko. He received a stock option for 5,248 shares and an award tied to 1,384 ordinary shares, both granted at $0.00 per share as compensation, not open-market trades.

How many Allegion (ALLE) shares are covered by Joseph Blasko’s new awards?

Joseph Blasko’s awards cover 6,632 Allegion-linked shares in total. The Form 4 shows a stock option over 5,248 shares and a separate grant linked to 1,384 ordinary shares, all classified as acquisitions rather than market purchases.

What is the vesting schedule for Joseph Blasko’s Allegion (ALLE) equity awards?

The awards vest in three equal annual installments starting in 2027. Both the restricted stock units and the stock option vest on February 19, 2027, February 19, 2028, and February 19, 2029, spreading the potential ownership benefits over three years.

Were there any Allegion (ALLE) share sales by Joseph Blasko in this Form 4?

No share sales were reported for Joseph Blasko in this filing. The Form 4 records two transactions, both coded as acquisitions related to equity compensation grants, with no indicated open-market buying or selling activity.

What role does Joseph Blasko hold at Allegion (ALLE) in this Form 4?

Joseph Blasko is identified as SVP and General Counsel of Allegion. The Form 4 notes he is an officer, not a director or 10% owner, and the reported transactions reflect equity compensation tied to his executive role.